Ausgabe 4/2017
Inhalt (28 Artikel)
Primary myelofibrosis and its targeted therapy
Lindsey Shantzer, Kristin Berger, Jeffrey J. Pu
Managing patients with myelofibrosis and low platelet counts
Haifa Kathrin Al-Ali, Alessandro M. Vannucchi
Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion
Massimo Breccia, Patrizia Pregno, Paolo Spallarossa, Eleonora Arboscello, Fabio Ciceri, Mauro Giorgi, Alberto Grossi, Mario Mallardo, Savina Nodari, Stefano Ottolini, Carla Sala, Giovanni Tortorella, Gianantonio Rosti, Fabrizio Pane, Giorgio Minotti, Michele Baccarani
Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy
Jan K. Hiller, Claudia Schmoor, Verena I. Gaidzik, Charlotte Schmidt-Salzmann, Arzu Yalcin, Mahmoud Abdelkarim, Nadja Blagitko-Dorfs, Konstanze Döhner, Lars Bullinger, Justus Duyster, Michael Lübbert, Björn Hackanson
Meis1 is critical to the maintenance of human acute myeloid leukemia cells independent of MLL rearrangements
Jiangying Liu, Ya-Zhen Qin, Shenmiao Yang, Yazhe Wang, Ying-Jun Chang, Ting Zhao, Qian Jiang, Xiao-Jun Huang
Second line azacitidine for elderly or infirmed patients with acute myeloid leukemia (AML) not eligible for allogeneic hematopoietic cell transplantation—a retrospective national multicenter study
Ron Ram, Moshe Gatt, Drorit Merkel, Ilana Helman, Tsofia Inbar, Arnon Nagler, Irit Avivi, Yishai Ofran
Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection
Miao Chen, Junling Zhuang, Daobin Zhou, Ying Xu, Yongqiang Zhao, Shujie Wang, Wei Zhang, Minghui Duan, Tienan Zhu, Jian Li, Huacong Cai, Xinxin Cao, Bing Han
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab
Ferras Alashkar, Colin Vance, Dörte Herich-Terhürne, Nicole Preising, Ulrich Dührsen, Alexander Röth
Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients
Ilham Youssry, Nohair Soliman, Mona Ghamrawy, Rania Mohamed Samy, Amal Nasr, Mohamed Abdel Mohsen, Mohamed ElShahaat, Rayan Bou Fakhredin, Ali Taher
Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience
Shin Hye Yoo, Youngil Koh, Dae-Young Kim, Jung-Hee Lee, Je-Hwan Lee, Kyoo-Hyung Lee, Sung-Soo Yoon, Seonyang Park, Sung-Kyu Park, Dae-Sik Hong, Hyeon Gyu Yi, Chul-Soo Kim, Ji Eun Jang, June-Won Cheong, Joonho Moon, Yoo Hong Min, Sang Kyun Sohn, Inho Kim
Nutritional risk in allogeneic stem cell transplantation: rationale for a tailored nutritional pathway
Takashi Aoyama, Osamu Imataki, Keita Mori, Kanako Yoshitsugu, Masafumi Fukaya, Ikue Okamura, Terukazu Enami, Raine Tatara, Takashi Ikeda
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma
Novella Pugliese, M. Di Perna, I. Cozzolino, G. Ciancia, G. Pettinato, P. Zeppa, V. Varone, S. Masone, C. Cerchione, R. Della Pepa, L. Simeone, C. Giordano, V. Martinelli, C. Salvatore, F. Pane, M. Picardi
Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial
Laura Magnano, Silvia Montoto, Eva González-Barca, Javier Briones, Juan Manuel Sancho, Ana Muntañola, Antonio Salar, Joan Besalduch, Lourdes Escoda, Carol Moreno, Eva Domingo-Domenech, Cristina Estany, Albert Oriol, Albert Altés, Carmen Pedro, Santiago Gardella, Antoni Asensio, Pilar Vivancos, Alberto Fernández de Sevilla, Josep María Ribera, Dolors Colomer, Elias Campo, Armando López-Guillermo
Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity
Thomas S. Y. Chan, Tsan-Hei Luk, June S. M. Lau, Pek-Lan Khong, Yok-Lam Kwong
The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry
Antoinetta J.M. Beijers, Simone Oerlemans, Floortje Mols, Marijke Eurelings, Monique C. Minnema, Art Vreugdenhil, Lonneke V. van de Poll-Franse
Comprehensive assessment of peripheral blood TCRβ repertoire in infectious mononucleosis and chronic active EBV infection patients
Shenglin Liu, Qian Zhang, Dongli Huang, Wenli Zhang, Fengluan Zhong, Jia Feng, Xueru Chen, Qingxiang Meng, Xiaofan Chen, Wei Zhang, Hongyu Zhang
Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate
Christian Arranto, Alexandar Tzankov, Jörg Halter
A treatment refractory CD30-positive diffuse large B cell lymphoma in the ileal neobladder
Saeko Ota, Toshiki Iwai, Yuka Kawaji, Takahiro Fujino, Muneo Ohshiro, Yoshiko Hirakawa, Yoshiaki Chinen, Hitoji Uchiyama, Hiroto Kaneko, Junya Kuroda
Transient hypophysitis in a patient treated by duvelisib for chronic lymphocytic leukemia
Laura Orioli, K. Sarti, E. Van Den Neste, D. Maiter
Successful treatment of refractory Sezary syndrome by anti-PD-1 antibody (nivolumab)
Kaini Shen, Yuehua Liu, Xinxin Cao, Daobin Zhou, Jian Li
Severe hepatitis B virus reactivation related to ibrutinib monotherapy
Yair Herishanu, Helena Katchman, Aaron Polliack
Successful treatment with apixaban of sinus venous thrombosis due to pegylated asparaginase in a young adult with T cell acute lymphoblastic leukemia: case report and review of management
Laura Talamo, Michael Douvas, B. Gail Macik, David Ornan
Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapy
Nicolas Belhomme, Adel Maamar, Thomas Le Gallou, Marie-Christine Minot-Myhié, Antoine Larralde, Nicolas Champtiaux, Olivier Benveniste, Sarah Leonard-Louis, Olivier Decaux, Alain Lescoat, Yves Le Tulzo
Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis
Claudio Cerchione, Ilaria Peluso, Davide Nappi, Anna Emanuele Pareto, Marco Picardi, Vincenzo Martinelli, Fabrizio Pane
Vaccination of allogeneic hematopoietic stem cell transplant recipients—what should be considered?
Inken Hilgendorf, Hildegard Greinix, Jörg Halter, Anita Lawitschka, Daniel Wolff
Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure
Eva Knüppel, Michael Medinger, Gregor Stehle, Laura Infanti, Jörg Halter, Felix Burkhalter, Edin Mujagic, Dominik Heim, Jakob Passweg
Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia
Xueya Zhang, Jingxin Pan
Histoplasma capsulatum in a peripheral blood smear in a non-HIV patient
Bhawna Jha, Smeeta Gajendra